Search PubMed⌕ Search

PubMed · 16131726

[Authorization for database research].

Abstract

It was characteristic of the discussion about the Icelandic Health Sector Database that its proponents laid heavy emphasis on technical security of health care information while the issue of consent for participation in the database was for them of minor significance. It was decided to have a policy of presumed consent which I find flawed from a moral standpoint. However, I do not agree with those critics who have demanded that informed consent for participation in research be obtained. While I think that explicit individual consent is of crucial significance, I argue that the traditional demand for informed consent is neither suitable nor desirable in this case. I argue that different types of consent are appropriate for obtaining genealogical, genetic and health care information that can be connected in database research. I describe an idea of a written authorization based on general information about intended research as an alternative to informed consent and presumed consent for the use of healthcare information. I also propose a more restricted authorization as an alternative to informed consent and open consent to the use of genetic information in database research.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Vilhjálmur Arnason. 2005. [Authorization for database research].. https://pubmed.ncbi.nlm.nih.gov/16131726/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Beyond the permissibility of embryonic and stem cell research: substantive requirements and procedural safeguards.

This report provides a comparative analysis of the regulation of embryonic stem cells and cloning research in 50 countries. The development of international stem cell consortia involving the exchange of materials, data and knowledge presumes 'policy know-how' on the varying positions and governing regulations of the various partners; knowledge is essential for the feasibility of such international collaborative projects. Across the spectrum of restrictive-to-liberal policies, requirements regarding the justification for or the setting of substantive limits on (i) embryo use and/or (ii) destruction in research are often present. These goals justify the regulation, the control and even the prohibition of embryonic stem cell and cloning research. Moreover, irrespective of whether a country adopts a restrictive or a liberal approach, there is significant symmetry in both the substantive and the procedural requirements. Procedural safeguards provide another layer of protection and control over the research. In reality, such safeguards may have a greater systemic impact than the substantive requirements. They can be subdivided into three broad categories: (i) safeguards relating to the stage of embryonic development, (ii) safeguards relating to the donors of blastocysts, gametes, embryos and somatic cells and (iii) requirements for research governance.

Ethics, Research↗